share_log

CVS Health | 10-Q: Quarterly report

CVS Health | 10-Q: Quarterly report

西维斯健康 | 10-Q:季度报表
美股sec公告 ·  05/01 06:44
Moomoo AI 已提取核心信息
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
CVS Health报告称,2024年第一季度的营业收入有所下降,营业收入从去年同期的34.46亿美元降至22.71亿美元。调整后的营业收入也从同比的43.70亿美元降至29.57亿美元。但是,尽管健康服务板块下滑,但该公司的总收入仍略有增长3.7%,达到884.37亿美元,这得益于医疗保健福利以及药房和消费者健康板块的增长。归属于CVS Health的净收入大幅下降了47.9%,从21.36亿美元降至11.13亿美元。医疗保健福利板块的总收入增长了24.6%,而健康服务板块的收入下降了9.7%。药房和消费者健康板块的收入增长了2.9%。CVS Health的未来计划包括增长其新的Cordavis、Oak Street Health和Signify Health业务,该公司预计将继续与客户分享更大的回扣、费用和折扣。该公司还预计,企业范围内的成本节约计划和效率投资将持续进行,以可持续地降低运营成本。
CVS Health报告称,2024年第一季度的营业收入有所下降,营业收入从去年同期的34.46亿美元降至22.71亿美元。调整后的营业收入也从同比的43.70亿美元降至29.57亿美元。但是,尽管健康服务板块下滑,但该公司的总收入仍略有增长3.7%,达到884.37亿美元,这得益于医疗保健福利以及药房和消费者健康板块的增长。归属于CVS Health的净收入大幅下降了47.9%,从21.36亿美元降至11.13亿美元。医疗保健福利板块的总收入增长了24.6%,而健康服务板块的收入下降了9.7%。药房和消费者健康板块的收入增长了2.9%。CVS Health的未来计划包括增长其新的Cordavis、Oak Street Health和Signify Health业务,该公司预计将继续与客户分享更大的回扣、费用和折扣。该公司还预计,企业范围内的成本节约计划和效率投资将持续进行,以可持续地降低运营成本。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息